Hostname: page-component-7b7567c8c-slfcl Total loading time: 0 Render date: 2026-11-19T14:57:00.031Z Has data issue: false hasContentIssue false

Mortality in hospitalized SARS-CoV-2 patients with contemporaneous bacterial and fungal infections

Published online by Cambridge University Press:  23 September 2024

John J. Hanna
Affiliation:
Information Services, ECU Health, Greenville, NC, USADivision of Infectious Diseases, Department of Internal Medicine, East Carolina University, Greenville, NC, USAClinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.
Zachary M. Most
Affiliation:
Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA
Lauren N. Cooper
Affiliation:
Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.
Abdi D. Wakene
Affiliation:
Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.
Alexander P. Radunsky
Affiliation:
Division of Infectious Diseases & Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
Christoph U. Lehmann
Affiliation:
Clinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.Division of Infectious Diseases, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USAO’Donnell School of Public Health, University of Texas Southwestern, Dallas, TX, USA
Trish M. Perl
Affiliation:
Division of Infectious Diseases & Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USAO’Donnell School of Public Health, University of Texas Southwestern, Dallas, TX, USA
Richard J. Medford*
Affiliation:
Information Services, ECU Health, Greenville, NC, USADivision of Infectious Diseases, Department of Internal Medicine, East Carolina University, Greenville, NC, USAClinical Informatics Center, University of Texas Southwestern, Dallas, TX, USA.
*
Corresponding author: Richard Medford; Email: medfordr23@ecu.edu

Abstract

Background:

The interplay between SARS-CoV-2 and contemporaneous bacterial or fungal culture growth may have crucial implications for clinical outcomes of hospitalized patients. This study aimed to quantify the effect of microbiological culture positivity on mortality among hospitalized patients with SARS-CoV-2.

Methods:

In this retrospective cohort study, we included adult hospitalized patients from OPTUM COVID-19 specific data set, who tested positive for SARS-CoV-2 within 14 days of hospitalization between 01/20/2020 and 01/20/2022. We examined outcomes of individuals with organisms growing on cultures from the bloodstream infections (BSIs), urinary tract, and respiratory tract, and a composite of the three sites. We used propensity score matching on covariates included demographics, comorbidities, and hospitalization clinical parameters. In a sensitivity analysis, we included same covariates but excluded critical care variables such as length of stay, intensive care unit stays, mechanical ventilation, and extracorporeal membrane oxygenation.

Results:

The cohort included 104,560 SARS-CoV-2 positive adult hospitalized patients across the United States. The unadjusted mortality odds increased significantly with BSIs (98.7%) and with growth on respiratory cultures (RC) (176.6%), but not with growth on urinary cultures (UC). Adjusted analyses showed that BSIs and positive RC independently contribute to mortality, even after accounting for critical care variables.

Conclusions:

In SARS-CoV-2-positive hospitalized patients, positive bacterial and fungal microbiological cultures, especially BSIs and RC, are associated with an increased risk of mortality even after accounting for critical care variables associated with disease severity. These findings underscore the importance of stringent infection control and the effective management of secondary infections to improve patient outcomes.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Characteristics and outcomes of bloodstream infections (BSIs) (patients with positive blood cultures) among hospitalizations with SARS-CoV-2 infection

Figure 1

Figure 1.Love plot post-propensity score matching for BSI with all included covariates in the population match.

Figure 2

Figure 2.Love plot post-sensitivity analysis propensity score matching for BSI without LOS, ECMO, mechanical ventilation, ICU.

Figure 3

Figure 3.Unadjusted OR for mortality after propensity score matching on all included covariates by type of infection; BSI, respiratory, urine, and all infections.

Figure 4

Figure 4.Unadjusted OR for mortality after propensity score matching on all covariates except LOS, mechanical ventilation, ICU, and ECMO by type of infection; BSI, respiratory, urine, and all infections.